Sheel Biotech IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Sep 30 to Oct 03 2025
Price Band
₹59 - 63
Current GMP
₹91.0 (+44.44%)
Subscription
15.97 times
IPO Details
| IPO Date | September 30, 2025 to October 3, 2025 |
| Listing Date | October 8, 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹59 to ₹63 per share |
| Issue Price Final | ₹63 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 54,00,000 shares (aggregating up to ₹34.02 Cr) |
| Reserved for Market Maker | 2,72,000 shares (aggregating up to ₹1.71 Cr)Mansi Share & Stock Broking Pvt.Ltd. |
| Net Offered to Public | 51,28,000 shares (aggregating up to ₹32.31 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,49,52,550 shares |
| Share Holding Post Issue | 2,03,52,550 shares |
IPO Date
September 30, 2025 to October 3, 2025
Listing Date
October 8, 2025
Face Value
₹10 per share
Issue Price Band
₹59 to ₹63 per share
Issue Price Final
₹63 per share
Lot Size
2,000 Shares
Sale Type
Fresh Capital
Total Issue Size
54,00,000 shares (aggregating up to ₹34.02 Cr)
Reserved for Market Maker
2,72,000 shares (aggregating up to ₹1.71 Cr)Mansi Share & Stock Broking Pvt.Ltd.
Net Offered to Public
51,28,000 shares (aggregating up to ₹32.31 Cr)
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Share Holding Pre Issue
1,49,52,550 shares
Share Holding Post Issue
2,03,52,550 shares
IPO Subscription Details
| Anchor Investors | 1 |
| Market Maker | 1 |
| QIB (Ex Anchor) | 19.73 |
| Non-Institutional Buyers*** | 25.92 |
| bNII (bids above ₹10L) | 31.64 |
| sNII (bids below ₹10L) | 14.49 |
| Individual Investors (IND category bidding for 2 Lots) | 9.56 |
| Total ** | 15.97 |
Anchor Investors
1
Market Maker
1
QIB (Ex Anchor)
19.73
Non-Institutional Buyers***
25.92
bNII (bids above ₹10L)
31.64
sNII (bids below ₹10L)
14.49
Individual Investors (IND category bidding for 2 Lots)
9.56
Total **
15.97
Day Wise Sub
| Day | QIB (Ex Anchor) | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Day 1 Sep 30, 2025 | 0.00 | 0.13 | 0.14 | 0.12 | 0.08 | 0.07 |
| Day 2 Oct 1, 2025 | 0.02 | 0.15 | 0.53 | 0.44 | 0.52 | 0.30 |
| Day 3 Oct 3, 2025 | 19.73 | 25.92 | 31.64 | 14.49 | 9.56 | 15.97 |
DayDay 1
Sep 30, 2025
QIB (Ex Anchor)0.00
NII*0.13
NII (> ₹10L)0.14
NII (< ₹10L)0.12
Individual Investors0.08
Total0.07
DayDay 2
Oct 1, 2025
QIB (Ex Anchor)0.02
NII*0.15
NII (> ₹10L)0.53
NII (< ₹10L)0.44
Individual Investors0.52
Total0.30
DayDay 3
Oct 3, 2025
QIB (Ex Anchor)19.73
NII*25.92
NII (> ₹10L)31.64
NII (< ₹10L)14.49
Individual Investors9.56
Total15.97
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 08-10-2025 | 63.00 | 16(25.40%) | 79 |
| 07-10-2025 | 63.00 | 16(25.40%) | 79 |
| 06-10-2025 | 63.00 | 10(15.87%) | 73 |
| 05-10-2025 | 63.00 | 10(15.87%) | 73 |
| 04-10-2025 | 63.00 | 10(15.87%) | 73 |
| 03-10-2025 | 63.00 | 8(12.70%) | 71 |
| 02-10-2025 | 63.00 | 4(6.35%) | 67 |
| 01-10-2025 | 63.00 | 4(6.35%) | 67 |
| 30-09-2025 | 63.00 | 0(0.00%) | 63 |
| 29-09-2025 | 63.00 | 0(0.00%) | 63 |
| 28-09-2025 | 63.00 | 5(7.94%) | 68 |
| 27-09-2025 | 63.00 | 5(7.94%) | 68 |
| 26-09-2025 | 63.00 | 0(0.00%) | 63 |
Date08-10-2025
Price63.00
GMP16(25.40%)
Estimate List Price79
Date07-10-2025
Price63.00
GMP16(25.40%)
Estimate List Price79
Date06-10-2025
Price63.00
GMP10(15.87%)
Estimate List Price73
Date05-10-2025
Price63.00
GMP10(15.87%)
Estimate List Price73
Date04-10-2025
Price63.00
GMP10(15.87%)
Estimate List Price73
Date03-10-2025
Price63.00
GMP8(12.70%)
Estimate List Price71
Date02-10-2025
Price63.00
GMP4(6.35%)
Estimate List Price67
Date01-10-2025
Price63.00
GMP4(6.35%)
Estimate List Price67
Date30-09-2025
Price63.00
GMP0(0.00%)
Estimate List Price63
Date29-09-2025
Price63.00
GMP0(0.00%)
Estimate List Price63
Date28-09-2025
Price63.00
GMP5(7.94%)
Estimate List Price68
Date27-09-2025
Price63.00
GMP5(7.94%)
Estimate List Price68
Date26-09-2025
Price63.00
GMP0(0.00%)
Estimate List Price63
IPO Important Dates
| IPO Open Date | Tue, Sep 30, 2025 |
| IPO Close Date | Fri, Oct 3, 2025 |
| Tentative Allotment | Mon, Oct 6, 2025 |
| Initiation of Refunds | Tue, Oct 7, 2025 |
| Credit of Shares to Demat | Tue, Oct 7, 2025 |
| Tentative Listing Date | Wed, Oct 8, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Oct 3, 2025 |
IPO Open Date
Tue, Sep 30, 2025
IPO Close Date
Fri, Oct 3, 2025
Tentative Allotment
Mon, Oct 6, 2025
Initiation of Refunds
Tue, Oct 7, 2025
Credit of Shares to Demat
Tue, Oct 7, 2025
Tentative Listing Date
Wed, Oct 8, 2025
Cut-off time for UPI mandate confirmation
5 PM on Fri, Oct 3, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,52,000 |
| Individual investors (Retail) (Max) | 2 | 4,000 | ₹2,52,000 |
| S-HNI (Min) | 3 | 6,000 | ₹3,78,000 |
| S-HNI (Max) | 7 | 14,000 | ₹8,82,000 |
| B-HNI (Min) | 8 | 16,000 | ₹10,08,000 |
ApplicationIndividual investors (Retail) (Min)
Lots2
Shares4,000
Amount₹2,52,000
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares4,000
Amount₹2,52,000
ApplicationS-HNI (Min)
Lots3
Shares6,000
Amount₹3,78,000
ApplicationS-HNI (Max)
Lots7
Shares14,000
Amount₹8,82,000
ApplicationB-HNI (Min)
Lots8
Shares16,000
Amount₹10,08,000
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 113.28 | 105.95 | 93.89 |
| Total Income | 102.27 | 92.55 | 80.19 |
| Profit After Tax | 10.64 | 10.47 | 5.08 |
| EBITDA | 14.97 | 14.45 | 8.83 |
| NET Worth | 83.85 | 72.69 | 63.54 |
| Reserves and Surplus | 68.90 | 68.58 | 59.40 |
| Total Borrowing | 17.36 | 23.54 | 19.17 |
Period EndedPeriod Ended
31 Mar 202531 Mar 2025
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Mar 2025113.28
31 Mar 2024105.95
31 Mar 202393.89
Period EndedTotal Income
31 Mar 2025102.27
31 Mar 202492.55
31 Mar 202380.19
Period EndedProfit After Tax
31 Mar 202510.64
31 Mar 202410.47
31 Mar 20235.08
Period EndedEBITDA
31 Mar 202514.97
31 Mar 202414.45
31 Mar 20238.83
Period EndedNET Worth
31 Mar 202583.85
31 Mar 202472.69
31 Mar 202363.54
Period EndedReserves and Surplus
31 Mar 202568.90
31 Mar 202468.58
31 Mar 202359.40
Period EndedTotal Borrowing
31 Mar 202517.36
31 Mar 202423.54
31 Mar 202319.17
Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | P/E (x) | RoNW (%) | Financial statements |
|---|---|---|---|---|---|
| Sheel Biotech Ltd. | 7.21 | 7.21 | 14.45 | ||
| Jain Irrigation Systems Limited | 0.36 | 0.36 | 143.97 | ||
| Vrundavan Plantation Ltd | 3.30 | 3.30 | 14.24 |
Company NameSheel Biotech Ltd.
EPS (Basic)7.21
EPS (Diluted)7.21
P/E (x)
RoNW (%)14.45
Financial statements
Company NameJain Irrigation Systems Limited
EPS (Basic)0.36
EPS (Diluted)0.36
P/E (x)143.97
RoNW (%)
Financial statements
Company NameVrundavan Plantation Ltd
EPS (Basic)3.30
EPS (Diluted)3.30
P/E (x)14.24
RoNW (%)
Financial statements
IPO Reservation
| Market Maker Shares Offered | 2,72,000 (5.04%) |
| QIB Shares Offered | 25,50,000 (47.22%) |
| − Anchor Investor Shares Offered | 15,24,000 (28.22%) |
| − QIB (Ex. Anchor) Shares Offered | 10,26,000 (19.00%) |
| NII (HNI) Shares Offered | 7,74,000 (14.33%) |
| − bNII > ₹10L | 5,16,000 (9.56%) |
| − sNII < ₹10L | 2,58,000 (4.78%) |
| Retail Shares Offered | 18,04,000 (33.41%) |
| Total Shares Offered | 54,00,000 (100.00%) |
Market Maker Shares Offered
2,72,000 (5.04%)
QIB Shares Offered
25,50,000 (47.22%)
− Anchor Investor Shares Offered
15,24,000 (28.22%)
− QIB (Ex. Anchor) Shares Offered
10,26,000 (19.00%)
NII (HNI) Shares Offered
7,74,000 (14.33%)
− bNII > ₹10L
5,16,000 (9.56%)
− sNII < ₹10L
2,58,000 (4.78%)
Retail Shares Offered
18,04,000 (33.41%)
Total Shares Offered
54,00,000 (100.00%)
Information about company
Incorporated in November 1991, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.
The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming.
The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs.
They also deliver landscaping services to the government and private sectors.
The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications, reflecting its commitment to quality, environmental responsibility, and safety.
The company's Research and Development laboratory is recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) of the Government of India.
Sheel Biotech offers a diverse range of services and products, including:
Planting Material: Utilizing tissue culture and hydroponics, the company produces high-quality, disease-free planting materials for various crops such as fruits, floriculture, forestry, and ornamentals.
Horticultural Projects: Sheel Biotech designs and implements greenhouses, centers of excellence, integrated packhouses, and other turnkey projects, incorporating modern technologies like climate control, automation, drip irrigation, and fertigation to optimize crop yield and quality.
Organic Adoption and Certification: The company assists farmers in transitioning to organic farming by providing adoption and certification services in line with the National Programme for Organic Production (NPOP) and the Participatory Guarantee System (PGS).
Farmer Producer Organization (FPO) Management: Sheel Biotech supports the establishment and management of FPOs, offering training, skill development, and market linkage assistance to enhance farmers' access to better services and inputs.
Skill Development: The company conducts training programs, seminars, workshops, and exposure trips to educate farmers and agripreneurs on modern agricultural practices and techniques.
As of September 12, 2025, the Company has 160 permanent employees on its payroll.
Competitive Strength:
Skilled in biotechnology, organic farming, and greenhouse management.
Offers a wide range of products across agriculture, floriculture, and horticulture.
Eco-friendly practices and a focus on organic, sustainable farming.
Objectives of IPO
The Company Sheel Biotech IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (in Millions)
1
Capital Expenditure Requirement
91.2
2
Working Capital Requirement
158.8
3
General Corporate Purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App